• Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Estonia +14

  • Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Greece Spain

  • Study Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Greece Italy Poland +1

  • Study on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy

    Not recruiting

    3 1
    Investigated Drugs:
    France Germany Greece Italy The Netherlands Slovakia +1

  • Study on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Hungary Italy Poland Romania Spain

  • Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study on the Safety and Effectiveness of AUTO1 for Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Using a Drug Combination

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Spain

  • Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Germany Latvia Poland Portugal Slovakia +2

  • Study of AMG 193 and IDE397 for Adults with Advanced MTAP-null Solid Tumors and Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Spain

  • Study on the Safety and Efficacy of Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain

powered by